Application and Demonstration of Endoscope-assisted Low-temperature Plasma Radiofrequency Ablation Resection of Tonsils

Launched by PEOPLE'S HOSPITAL OF ANSHUN CITY OF GUIZHOU PROVINCE · May 14, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring a new method for treating tonsil disease using a technique called low-temperature plasma radiofrequency ablation. This procedure allows doctors to use a small camera (endoscope) to see the tonsils clearly while treating them. The benefits of this method include less pain after surgery, reduced bleeding, and quicker recovery times for patients. The trial aims to show how effective and safe this approach can be, making it a promising option for those suffering from chronic tonsillitis.

To be eligible for the trial, participants should be between 3 and 65 years old and have experienced frequent bouts of tonsillitis (more than three times a year for over two years), along with issues like snoring or breathing problems during sleep. It’s important that participants do not have serious health conditions that could complicate the surgery. Those who join the study can expect a gentle procedure that aims to improve their tonsil-related issues while being closely monitored by healthcare professionals.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. History of recurrent acute attacks of chronic tonsillitis, with the number of attacks \>3 times per year for more than 2 years;
• • 2. accompanied by snoring, choking and apnea during night sleep;
• • 3. Age 3-65 years old, gender is not limited;
• • 4. No major systemic diseases, such as cardiovascular and cerebrovascular diseases, liver and kidney insufficiency, hematopoietic system diseases;
• • 5. Subjects who can understand and abide by the research procedures and voluntarily participate in the experiment by signing the informed consent form (the informed consent is signed by themselves or their legal representatives).
• Exclusion Criteria:
• • 1. cardiopulmonary insufficiency;
• • 2. Patients with systemic blood diseases;
• • 3. Patients with acute and chronic bronchial or lung infections;
• • 4. Complicated with severe cardiovascular system disease or hepatic and renal insufficiency;
• • 6) Patients with mental abnormalities or who do not cooperate with treatment 7) Researchers who are participating in other trials.